WeVote
Log In

Bill

Bill

SB 19

PHARMACEUTICALS: Provides relative to the dispensing of ivermectin. (gov sig)

2025 Regular Session Introduced by Beryl Amedée and 15 co-sponsors

Louisiana law SB 19 modifies ivermectin dispensing regulations, taking effect June 20, 2025, though specific scope of changes remains undefined in available documentation.

Signed by the Governor. Becomes Act No. 464.
0
WeVote Research Nonpartisan
Bill Summary · SB 19

Legislative bill overview

SB 19 modifies Louisiana's pharmaceutical regulations to allow the dispensing of ivermectin under conditions specified in the bill. The bill became Act No. 464 and took effect on June 20, 2025. The specific provisions regarding prescribing authority, dosage limits, or intended uses are not detailed in the legislative record provided.

Why is this important

Ivermectin access affects public health policy, as the medication has approved uses for parasitic infections but has been subject to controversy regarding off-label applications. Changes to dispensing rules can impact how healthcare providers and pharmacists manage medication distribution and patient access.

Potential points of contention

  • Off-label use concerns: Ivermectin gained attention during COVID-19 for potential off-label use despite limited clinical evidence; clarity on whether this bill expands such access remains unclear from the summary
  • Medical oversight: The bill's scope regarding pharmacist authority versus physician prescription requirements and whether it reduces clinical gatekeeping
  • Public health messaging: Potential confusion between approved parasitic infection treatments and contested uses, depending on the bill's specific dispensing allowances

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.